FemHealth Focus
Kazia’s Paxalisib Disrupts Circulating Tumour Cell Clusters in HER2-Positive Metastatic Breast Cancer Study
Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, today announced new findings from a collaborative research program...
September 12, 2025 | News
Siemens Healthineers–YouGov Survey Reveals Fragmented Cancer Care Pathway in Southeast Asia, Underscoring Need for Integrated Solutions
YouGov survey finds strong belief in value of early detection (78%) but low screening uptake (26%) 80% of respondents aware post-treatment care exists...
September 10, 2025 | Report
Fairtility Achieves U.S. FDA Clearance, Expanding Global Footprint of CHLOE AI Embryo Assessment Platform
Fairtility, a global leader in transparent AI for reproductive care, announced that its CHLOE platform has achieved U.S. Food and Drug Administration...
September 05, 2025 | News
Lunit Secures Milestone European Deployment in Spain’s Valencian Community for AI-Powered Breast Cancer Screening
Milestone European deployment underscores growing global trust in Lunit's AI for population-wide breast cancer screening Lunit , a leading provider o...
September 03, 2025 | News
Basecare Medical Secures NMPA Approval For VitBase Culture Medium Marking Breakthrough In China’s Assisted Reproductive Field
Suzhou Basecare Medical Co., Ltd. achieved a major breakthrough—its globally leading Gems culture medium (embryo handling solution VitBase) has offic...
August 27, 2025 | Regulatory
Abbott Secures Thailand Approval For Denosumab Biosimilar Expanding Access To Osteoporosis Treatment
Abbott denosumab biosimilar has received regulatory approval in Thailand, expanding access to advanced therapies for osteoporosis and cancer-related bone l...
August 27, 2025 | News
QT Imaging secures $33M exclusive distribution deal with Gulf Medical for breast imaging scanners in Saudi Arabia
Shipments of five scanners per quarter starting on Q1’26 for total revenue of approximately $33 million over three years QT Imaging H...
August 26, 2025 | News
Anixa Biosciences Advances Phase 1 Trial of FSHR-Targeted CAR-T Therapy for Recurrent Ovarian Cancer
Anixa Biosciences, Inc. a biotechnology company focused on the treatment and prevention of cancer, announced that the second patient in th...
August 19, 2025 | News
SOPHiA GENETICS and AstraZeneca Expand AI Collaboration to Advance Personalised Breast Cancer Care
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine,announced an expansion of its...
August 06, 2025 | News
Bracco Imaging’s SonoVue® Gains NMPA Approval for HyCoSy Use in Infertility Diagnosis in China
Bracco Imaging, a global leader in diagnostic imaging,announced that its ultrasound contrast agent SonoVue® has been approved by the China's&...
August 06, 2025 | News
Alphamab Oncology’s HER2-Targeting ADC JSKN003 Secures FDA Orphan Drug Designation for Gastric and GEJ Cancers
Alphamab Oncology announced that anti-HER2 biparatopic antibody-drug conjugate (ADC) JSKN003 has been granted Orphan Drug Designation (ODD) by the U.S. Foo...
July 29, 2025 | News
Bayer’s Elinzanetant Faces FDA Review Extension, No Concerns Raised on Approvals
Bayer announced that the U.S. Food and Drug Administration (FDA) has extended the review period for the New Drug Application (NDA) for elinzanetant. Elinza...
July 28, 2025 | News
The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
The region’s women’s digital health market is projected to grow to $ 2,295.7 million by 2030, according to Grand View Research. This surge refl...
July 17, 2025 | News
DKSH Partners with Bayer to Expand Access to Cardiovascular and Women’s Health Products Across Southeast Asia
DKSH has signed a strategic business partnership with life science company Bayer, to provide comprehensive services for a portion of t...
July 10, 2025 | News
Most Read
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- How Health Systems Are Reshaping Drug Adoption, Partner Models, and Market Access in 2026
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
